Logo image
An exploratory randomized controlled trial of an AI-enabled mental health intervention for generalized anxiety
Journal article   Open access   Peer reviewed

An exploratory randomized controlled trial of an AI-enabled mental health intervention for generalized anxiety

Andrew Allen, Allan H. Young, Francine C. Jellesma, Anton Vorobev, Evgeniia Ivanova, Nikolay Babakov, Ani Gisnarian and Lee Kannis-Dymand
Journal of Affective Disorders, Vol.401, pp.1-12
2026
PMID: 41633449
pdf
1-s2.0-S0165032726001266-main3.18 MBDownloadView
Published Version Open Access CC BY V4.0

Abstract

mental health apps digital health congitive behaviour therapy artificial intelligence depression anxiety
Generalized Anxiety Disorder (GAD) is prevalent and often co-occurs with depression, contributing to significant disability and healthcare burden. Although treatments such as CBT and SSRIs are effective, access remains limited. This exploratory, randomized controlled trial evaluated the effectiveness of an AI-powered mental health app (PATH) in reducing symptoms of anxiety and depression. A total of 316 UK-based participants (aged 19-70) were randomized to either the intervention group (PATH) or a control group (NHS self-help website). The intervention provided evidence-based strategies including CBT-informed chat therapy and interactive tools. Anxiety (GAD-7) and depression (PHQ-9) scores were measured at baseline, two, eight, and twelve weeks. Of the 316 randomized participants, 235 completed the post-intervention assessment (33.0% attrition in the intervention group vs. 18.5% in the control group). Retention at 8-week and 12-week follow-ups was 77.4% and 54.0%, respectively. At two weeks, the intervention group showed significantly lower GAD-7 and PHQ-9 scores compared to control, with medium effect sizes. At eight weeks, those who continued using the app showed significant reductions in both anxiety and depression, while those who discontinued still showed medium improvements in anxiety. Effects were maintained at twelve weeks, with moderate to large effect sizes. Findings suggest that PATH significantly reduces anxiety and depressive symptoms, particularly with continued use. These results support the app's potential as a scalable, accessible digital intervention to address mental health treatment gaps.

Details

Metrics

186 File views/ downloads
13 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Clinical Neurology
Psychiatry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs from InCites

Logo image